Clinical Trials · NCT05548647

Semaglutide Treatment, Appetite, and Eating Behavior: Long-term Effects

CompletedPhase 4Semaglutide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
University of Pennsylvania
Enrollment
120
Start date
Jul 2022
Locations
1 site, United States
Primary endpoint
Study 1 Ad Libitum Energy Intake (kcal) During a Buffet Lunch Meal (4 Hrs After Standardized Breakfast)
View Semaglutide compound reference